aripiprazole has been researched along with fauc 346 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckler, F; Gmeiner, P; Hocke, C; Hübner, H; Kuwert, T; Prante, O; Salama, I; Utz, W | 1 |
| Gmeiner, P; Hübner, H; Kling, RC; Möller, D; Salama, I | 1 |
2 other study(ies) available for aripiprazole and fauc 346
| Article | Year |
|---|---|
Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
Topics: Animals; Benzamides; Fluorine Radioisotopes; In Vitro Techniques; Ligands; Models, Molecular; Molecular Conformation; Piperazines; Positron-Emission Tomography; Quantitative Structure-Activity Relationship; Radioligand Assay; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Swine | 2007 |
1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
Topics: Antipsychotic Agents; Binding Sites; HEK293 Cells; Humans; Ligands; Molecular Docking Simulation; Piperazines; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2 | 2015 |